Effect of yoga on altered mental process due to chemotherapy in lung cancer patient.

Efficacy of yoga on patients with chemotherapy induced cognitive impairment (CICI) in lung cancer at tertiary care center, Mumbai- A Phase II randomized controlled trial. - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104173

Enrollment

Registered

2026-02-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung

Interventions

Intervention1: Interventions: 1. Superbrain Yoga 2. Sidhha Walk 3. Bhastrika 4. Kapalbhati 5. Bhramari: 1. SELECTION OF PARTICIPANT Participants will be selected those meeting inclusion and exclusion

demonstration will be given to the experimental group participants by the investigators. Frequency of each exercise is 3 times a day, total duration of five exercises is 25 minutes a day in each time.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients histologically proven with lung cancer with or without metastasis. 2. Age 18 years to 75 years. 3. Patient receiving third or fourth cycle of chemotherapy. 4. Receiving chemotherapy alone or with immunotherapy or targeted therapy. 5. Patient who are able to implement the planned interventional exercises.

Exclusion criteria

Exclusion criteria: 1. Patients receiving only immunotherapy or targeted therapy. 2. Pre-existing cognitive impairment such as dementia, Alzheimer s, Epilepsy, Parkinson s, Traumatic brain injury, Cerebro vascular accident-related cognitive dysfunction. 3. Complications such as pneumothorax, pain, thrombocytopenia, peripheral neuropathy, preventing the performance of the study exercise. 4. Unable to perform due to any existing factors such as musculoskeletal problems. 5. The patient practicing yoga in their own form.

Design outcomes

Primary

Measure	Time frame
To compare the proportion of cancer patients undergoing chemotherapy who demonstrate a clinically meaningful improvement (more than equal to 10 point increase) in ACE III cognitive scores at Day 30 between the yoga intervention group and the control groupTimepoint: Baseline i.e. Day 0 to Day 30	—

Secondary

Measure	Time frame
To identify the degree of cognitive impairment and to see the trend of changes in cognition measured by ACE III scale among the experimental and control group of lung cancer patient at tertiary care centre.Timepoint: Baseline i.e. Day 0 to day 30	—

Countries

India

Contacts

Public ContactMiss Shruti J Ramteke

College of Nursing, Tata Memorial Hospital, Mumbai

prathepa_jagadish@rediffmail.com09869220441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026